Skip to main content
Ritesh International Ltd logo

Ritesh International Ltd — Investor Relations & Filings

Ticker · 519097 ISIN · INE534D01014 LEI · 335800C5M6C2387ZLF47 BSE.NS Manufacturing
Filings indexed 451 across all filing types
Latest filing 2023-07-13 Regulatory Filings
Country IN India
Listing BSE.NS 519097

About Ritesh International Ltd

https://www.riteshinternationalltd.com/

Ritesh International Ltd specializes in the manufacturing and distribution of oleochemicals, primarily focusing on stearic acid, fatty acids, and refined glycerine. The company operates processing facilities that utilize high-pressure splitting and vacuum distillation technologies to produce high-purity chemical intermediates. Its product portfolio includes various grades of stearic acid used in the production of rubber, PVC, and textiles, as well as refined glycerine for pharmaceutical and cosmetic applications. The firm serves as a supplier to manufacturers of soaps, detergents, and plastic additives, emphasizing process efficiency and product consistency to meet the technical requirements of diverse industrial sectors.

Recent filings

Filing Released Lang Actions
Certificate under Regulation 74(5) for quarter ended 30th June 2023 is attached herewith
Regulatory Filings
2023-07-13 English
Closure of trading window The trading window shall remain closed for all insiders including designated persons from 1st July 2023 till the expiry of 48 hours from the declaration of the ....
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the closure of the trading window for insiders as per SEBI regulations, related to the upcoming declaration of un-audited financial results for the quarter ended June 30, 2023. It does not contain any financial data or detailed report but is a regulatory compliance notice informing about trading restrictions. The document length is only 1229 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2023-06-29 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ritesh Arora & PACs
Regulatory Filings
2023-06-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ritesh Arora & PACs
Regulatory Filings
2023-06-09 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ritesh Arora & PACs
Regulatory Filings
2023-06-05 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ritesh Arora & PACs
Regulatory Filings
2023-06-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.